"
Team:Waterloo
From 2014.igem.org
(Difference between revisions)
(adds blueongrey class) |
(less margin) |
||
| Line 14: | Line 14: | ||
</div> | </div> | ||
<!--Content below images--> | <!--Content below images--> | ||
| - | <div class="content"> | + | <div class="content" style="margin-top: 0px;"> |
<div class="tabcontents"> | <div class="tabcontents"> | ||
<div class="anchor" id="view0" style="padding-top:0px;"> | <div class="anchor" id="view0" style="padding-top:0px;"> | ||
Revision as of 22:17, 17 October 2014
Staphylocide
Delivering Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation
Problem
MRSA is sweeping the nation, an antibiotic-resistant scourge migrating from hospitals into communities. We need a hero to fight it and Waterloo iGEM has designed a synthetic bacterium that just might do the trick...
Solution
...Staphylocide! Staphylocide delivers antibiotic resistance gene silencing in vivo and could one day be incorporated into a treatment that would help doctors defeat MRSA once and for all.
Project Cornerstones
Explore the three cornerstones of this year's project: delivering the silencing in vivo using conjugation, silencing mecA expression using CRISPRi and sRNA and translating from the lab to the patients.
